Instead, in CLL, the CCR7 surface over-expression does correlate with enhanced migration in response to CCR7 ligands, with this chemotactic response being more effective in CLL cells than in normal B cells (42, 48, 49, 55). This evidence concerns the gene CCR7 and B-cell chronic lymphocytic leukemia.